Physician profile
Brian David Dalm
NPI 1568699551
$43,418.99
in general payments reported to CMS, 2019-2025
15 companies · $17K in 2025
The $17K reported for 2025 was more than what 89% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,480 · 2020: $207 · 2021: $1,126 · 2022: $2,610 · 2023: $17K · 2024: $1,531 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,775 · Travel and Lodging: $7,882 · Food and Beverage: $5,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,050.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,775.00 |
| Travel and Lodging | $7,881.88 |
| Food and Beverage | $5,288.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,215.71 | 2020-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Percept Pc Brainsense |
| Abbott Laboratories | $10,568.93 | 2019-2025 | Infinity, Eterna |
| Siemens Medical Solutions USA, INC. | $9,036.05 | 2023-2024 | Varian Treatment, Varian Ethos Treatment Planning, Edge |
| Medtronic USA, INC. | $2,674.41 | 2019-2020 | |
| Clearpoint Neuro, INC. | $2,420.41 | 2023-2025 | Clearpoint |
| Surgical Information Sciences, INC. | $2,250.00 | 2022-2023 | Sis System |
| Boston Scientific Corporation | $1,456.69 | 2019-2025 | General - Therapies, Intracept, General - Dbs |
| Biogen, INC. | $1,226.00 | 2022 | |
| Biotronik Nro, INC. | $1,217.30 | 2025 | Prospera |
| Nevro Corp. | $221.76 | 2019-2023 | Senza |
| Kci USA, INC. | $52.84 | 2021 | |
| Mml US, INC. | $50.46 | 2023 | Reactiv8 |
| Depuy Synthes Sales INC. | $21.32 | 2019 | |
| Elutia, INC. | $7.11 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dalm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.